Particulates of a CRTH2 antagonist
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 13, 2013
Grant Date -
Mar 3, 2011
app pub date -
Jun 18, 2008
filing date -
Jun 21, 2007
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Provided herein are particulates of {4,6-bis(dimethylamino)-2-(4-(4-(trifluoromethyl)benzamido)benzyl)pyrimidin-5-yl}acetic acid in amorphous or crystalline forms, processes for their preparation, pharmaceutical compositions comprising them, and methods of their use for treating, preventing, or ameliorating one or more symptoms of a CRTH2-mediated disorder or disease.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully